Chairman – CEO
Dr. Ibrahim Shalaby joined Amecath in 2017 to lead the company’s international expansion after a 30-year medical industry career including senior positions with leading pharmaceutical companies Ranbaxy Pharmaceutical Company, Abbott Laboratories, Hoffmann La Roche and Schering Plough, in Saudi Arabia, the UAE, Egypt, covering the Middle East, Turkey, Iran and Pakistan. He is also an advisor, facilitator and faculty member of the Middle East Leadership Academy (MELA) and a member of the Association of Friends of the National Cancer- Free Initiative.
Dr. Shalaby carries the Medal of the Egyptian National Honor List, which was awarded to him in January 2016. He holds a Bachelor of Medicine and Surgery from the Faculty of Medicine, Cairo University, and a Master’s degree in Clinical Oncology.
Dr. Shalaby has authored numerous books in Arabic language and was granted prestigious accolades as a writer and author; his book “Exiting the Bubble” won the Young Adult Book of the Year Award (Etisalat Award) in November 2015 to name only one.